Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01366573 · ClinicalTrials.gov registry record · Phase 1

GSK1521498 Alcohol Interaction Study

A Phase 1 study of Alcoholism, sponsored by GlaxoSmithKline.

Completed
Registry status
Phase 1
Development phase
1
Enrollment target
1
Study location

NCT01366573 is a Phase 1 study of Alcoholism that has completed, run by GlaxoSmithKline. The registered enrollment target is 1 participants, below the 375-participant average among 65 other Alcoholism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01366573, a Phase 1 study of Alcoholism, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
Phase 1
Development phase
1 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to assess the safety and tolerability of GSK1521498 in combination with alcohol and to determine the amount of GSK1521498 and alcohol in your blood after you have been given these together. The study will also determine whether GSK1521498 will have an effect on alcohol liking and consumption.

Conditions Studied

Alcoholism

Interventions

  • OTHER Placebo
  • DRUG GSK1521498

Study Locations (1)

Texas

  • GSK Investigational Site - Austin

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2011-05-13
Est. Completion 2011-09-16
Phase Phase 1

Sponsor

GlaxoSmithKline

1,345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01366573

The ClinicalTrials.gov registry entry for NCT01366573 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 375-participant average among 65 other Alcoholism trials with a reported enrollment target (100% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcoholism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01366573 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01366573 about?

NCT01366573 is a clinical study titled "GSK1521498 Alcohol Interaction Study". The aim of the study is to assess the safety and tolerability of GSK1521498 in combination with alcohol and to determine the amount of GSK1521498 and alcohol in your blood after you have been given these together. The study will also determine whether GSK1521498 will have an effect on alcohol liking...

What is the current status of trial NCT01366573?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2011-05-13. Estimated completion is 2011-09-16.

What conditions does trial NCT01366573 study?

This clinical trial studies the following conditions: Alcoholism.

What interventions are being tested in trial NCT01366573?

The interventions under investigation include: Placebo (OTHER), GSK1521498 (DRUG).

Who is sponsoring clinical trial NCT01366573?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01366573 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcoholism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcoholism

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.